Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Budesonide (BUD) Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Nasal Spray
  • 1.3.3 Inhaler
  • 1.3.4 Pill&Rectal Forms
• 1.4 Market Segment by Application
  • 1.4.1 Global Budesonide (BUD) Market Share by Application (2019-2025)
  • 1.4.2 Respiratory Disease Treatment
  • 1.4.3 Nose Disease Treatment
  • 1.4.4 Inflammatory Bowel Disease Treatment
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Budesonide (BUD) Market Size
  • 2.1.1 Global Budesonide (BUD) Revenue 2014-2025
  • 2.1.2 Global Budesonide (BUD) Sales 2014-2025
• 2.2 Budesonide (BUD) Growth Rate by Regions
  • 2.2.1 Global Budesonide (BUD) Sales by Regions 2014-2019
  • 2.2.2 Global Budesonide (BUD) Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Budesonide (BUD) Sales by Manufacturers
  • 3.1.1 Budesonide (BUD) Sales by Manufacturers 2014-2019
  • 3.1.2 Budesonide (BUD) Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Budesonide (BUD) Revenue by Manufacturers (2014-2019)
  • 3.2.2 Budesonide (BUD) Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Budesonide (BUD) Market Concentration Ratio (CR5 and HHI)
• 3.3 Budesonide (BUD) Price by Manufacturers
• 3.4 Key Manufacturers Budesonide (BUD) Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Budesonide (BUD) Market
• 3.6 Key Manufacturers Budesonide (BUD) Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Nasal Spray Sales and Revenue (2014-2019)
  • 4.1.2 Inhaler Sales and Revenue (2014-2019)
  • 4.1.3 Pill&Rectal Forms Sales and Revenue (2014-2019)
• 4.2 Global Budesonide (BUD) Sales Market Share by Type
• 4.3 Global Budesonide (BUD) Revenue Market Share by Type
• 4.4 Budesonide (BUD) Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Budesonide (BUD) Sales by Application

6 United States

• 6.1 United States Budesonide (BUD) Breakdown Data by Company
• 6.2 United States Budesonide (BUD) Breakdown Data by Type
• 6.3 United States Budesonide (BUD) Breakdown Data by Application

7 European Union

• 7.1 European Union Budesonide (BUD) Breakdown Data by Company
• 7.2 European Union Budesonide (BUD) Breakdown Data by Type
• 7.3 European Union Budesonide (BUD) Breakdown Data by Application

8 China

• 8.1 China Budesonide (BUD) Breakdown Data by Company
• 8.2 China Budesonide (BUD) Breakdown Data by Type
• 8.3 China Budesonide (BUD) Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Budesonide (BUD) Breakdown Data by Company
• 9.2 Rest of World Budesonide (BUD) Breakdown Data by Type
• 9.3 Rest of World Budesonide (BUD) Breakdown Data by Application
• 9.4 Rest of World Budesonide (BUD) Breakdown Data by Countries
  • 9.4.1 Rest of World Budesonide (BUD) Sales by Countries
  • 9.4.2 Rest of World Budesonide (BUD) Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AstraZeneca
  • 10.1.1 AstraZeneca Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.1.4 Budesonide (BUD) Product Introduction
  • 10.1.5 AstraZeneca Recent Development
• 10.2 Cosmo Pharmaceuticals
  • 10.2.1 Cosmo Pharmaceuticals Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.2.4 Budesonide (BUD) Product Introduction
  • 10.2.5 Cosmo Pharmaceuticals Recent Development
• 10.3 Teva
  • 10.3.1 Teva Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.3.4 Budesonide (BUD) Product Introduction
  • 10.3.5 Teva Recent Development
• 10.4 Mylan
  • 10.4.1 Mylan Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.4.4 Budesonide (BUD) Product Introduction
  • 10.4.5 Mylan Recent Development
• 10.5 Sandoz
  • 10.5.1 Sandoz Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.5.4 Budesonide (BUD) Product Introduction
  • 10.5.5 Sandoz Recent Development
• 10.6 Dr. Falk Pharma
  • 10.6.1 Dr. Falk Pharma Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.6.4 Budesonide (BUD) Product Introduction
  • 10.6.5 Dr. Falk Pharma Recent Development
• 10.7 Chiesi Farmaceutici S.p.A
  • 10.7.1 Chiesi Farmaceutici S.p.A Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.7.4 Budesonide (BUD) Product Introduction
  • 10.7.5 Chiesi Farmaceutici S.p.A Recent Development
• 10.8 Orion Corporation
  • 10.8.1 Orion Corporation Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.8.4 Budesonide (BUD) Product Introduction
  • 10.8.5 Orion Corporation Recent Development
• 10.9 Cipla
  • 10.9.1 Cipla Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.9.4 Budesonide (BUD) Product Introduction
  • 10.9.5 Cipla Recent Development
• 10.10 Synmosa Biopharma Corporation
  • 10.10.1 Synmosa Biopharma Corporation Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Budesonide (BUD)
  • 10.10.4 Budesonide (BUD) Product Introduction
  • 10.10.5 Synmosa Biopharma Corporation Recent Development
• 10.11 Lunan Better Pharmaceutical
• 10.12 Shanghai Sine Promod Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Budesonide (BUD) Sales Channels
  • 11.2.2 Budesonide (BUD) Distributors
• 11.3 Budesonide (BUD) Customers

12 Market Forecast

• 12.1 Global Budesonide (BUD) Sales and Revenue Forecast 2019-2025
• 12.2 Global Budesonide (BUD) Sales Forecast by Type
• 12.3 Global Budesonide (BUD) Sales Forecast by Application
• 12.4 Budesonide (BUD) Forecast by Regions
  • 12.4.1 Global Budesonide (BUD) Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Budesonide (BUD) Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Budesonide (BUD) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Budesonide (BUD).

This report studies the global market size of Budesonide (BUD), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Budesonide (BUD) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

Market Segment by Product Type
Nasal Spray
Inhaler
Pill&Rectal Forms

Market Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Budesonide (BUD) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Budesonide (BUD) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Budesonide (BUD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025